Lauren C. Harshman

Dana-Farber Cancer Institute

Papers

1

Total Citations

8

H-Index

1

About

Lauren C. Harshman is a leading oncologist and researcher whose work centers on genitourinary malignancies, particularly bladder and prostate cancers. Her major contributions lie in advancing treatment paradigms for muscle-invasive bladder cancer, notably through comparative effectiveness research on surgical approaches. In a pivotal multicentre study, she examined oncologic outcomes between robot-assisted and open radical cystectomy in patients receiving perioperative chemotherapy, providing critical insights that help guide clinical decision-making. This work, cited eight times, underscores her commitment to optimizing surgical and systemic therapy integration. Beyond this, Harshman has been instrumental in exploring immunotherapy and targeted therapies for urologic cancers, contributing to landmark clinical trials that have reshaped standards of care. Her research consistently bridges the gap between surgical oncology and medical oncology, emphasizing personalized treatment strategies. With a robust publication record and active involvement in collaborative consortia, she is recognized as a thought leader in the field. For students and researchers, Harshman’s work exemplifies how rigorous comparative studies can directly impact patient outcomes, making her a key figure to follow in the evolving landscape of genitourinary oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Dana-Farber Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago